Sartans Market Trends And Growth Drivers Point To Strong Future Potential
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Sartans Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The sartans market has experienced consistent expansion over recent years. From $22.18 billion in 2025, it is expected to increase to $23.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.1%. This historical rise has been driven by several factors: the widespread prevalence of hypertension worldwide, the significant burden of cardiovascular diseases, growing uptake of generic medications, frequent reliance on hospital-based prescribing practices, and sartans’ established long-term safety record.
The size of the sartans market is projected to increase steadily in the coming years, reaching a value of $27.14 billion by 2030, with a compound annual growth rate (CAGR) of 4.1%. This anticipated growth during the forecast period is driven by the aging global population, a rising prevalence of kidney disease, the demand for affordable therapeutic options, the expansion of outpatient care services, and the emergence of digital pharmacies. Key developments shaping this period include a growing reliance on sartans for managing hypertension, the proliferation of generic angiotensin receptor blockers, a shift toward combination therapies for cardiovascular health, the broadening reach of online pharmacy channels, and increased emphasis on protecting both renal and cardiovascular functions.
Download A Free Sample Report For Comprehensive Market Insights:
Sartans Market Industry Drivers: What Is Driving Revenue Growth?
The anticipated expansion of the sartans market is being driven forward by the growing frequency of hypertension cases. Hypertension is a medical condition characterized by consistently elevated blood pressure, which increases the risk of heart disease, stroke, and other serious health issues. Its increasing occurrence is associated with diets heavy in salt and processed foods, which cause fluid retention and put extra strain on the heart. Sartans address hypertension by blocking angiotensin II, a hormone responsible for narrowing blood vessels. This action helps relax and widen the vessels, thereby lowering blood pressure and reducing the workload on the heart. According to the World Health Organization, a Switzerland-based international public health agency, an estimated 1.4 billion adults aged 30 to 79 globally were living with hypertension in 2024, accounting for roughly 33% of the world’s population, as reported in September 2025. Consequently, the rising prevalence of hypertension is fueling growth within the sartans market.
Sartans Market Segmentation And Category Breakdown
The sartans market covered in this report is segmented –
1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
4) By End-User: Hospitals, Other End-Users
Subsegments:
1) By Valsartan: Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations
2) By Telmisartan: Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules
3) By Losartan: Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets
4) By Irbesartan: High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs
5) By Azilsartan: Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets
6) By Olmesartan: Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets
Sartans Market Growth Trends: What Is Influencing The Future Outlook?
Key players in the sartans market are prioritizing the creation of innovative tablet-form sartans aimed at boosting therapeutic effectiveness and improving patient compliance. These oral medications consist of sartan drugs that work by inhibiting angiotensin II, thereby helping blood vessels relax and lowering blood pressure. A notable example occurred in July 2024, when Zydus Lifesciences, a pharmaceutical firm based in India, secured approval from the US Food and Drug Administration (FDA) for its Valsartan Tablets USP, available in 40 mg and 80 mg strengths, with the brand name Diovan. These tablets are indicated for managing hypertension and heart failure, as well as enhancing survival rates following heart attacks in adults, and they are also appropriate for pediatric patients aged one year and older.
Sartans Market Competitive Analysis Of Major Industry Participants
Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.
Access The Complete Sartans Market Report:
Sartans Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
